Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 22

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 3
Chunk 22
---
 we may not have adequate remedies for any
breach. In addition, our trade secrets and intellectual property may otherwise become known or be independently discovered by competitors.

We
cannot provide any assurances that our trade secrets and other confidential proprietary information will not be disclosed in violation
of our confidentiality agreements or that competitors will not otherwise gain access to our trade secrets or independently develop substantially
equivalent information and techniques. Also, misappropriation or unauthorized and unavoidable disclosure of our trade secrets and intellectual
property could impair our competitive position and may have a material adverse effect on our business. Additionally, if the steps taken
to maintain our trade secrets and intellectual property are deemed inadequate, we may have insufficient recourse against third parties
for misappropriating any trade secret.

Intellectual
property rights of third parties could adversely affect our ability to commercialize our products, and we might be required to litigate
or obtain licenses from third parties in order to develop or market our SaverOne systems. Such litigation or licenses could be costly
or not available on commercially reasonable terms.

It
is inherently difficult to conclusively assess our freedom to operate without infringing on third party rights. Our competitive position
may be adversely affected if existing patents or patents resulting from patent applications issued to third parties or other third-party
intellectual property rights are held to cover our products or elements thereof, or our manufacturing or uses relevant to our development
plans. In such cases, we may not be in a position to develop or commercialize products unless we successfully pursue litigation to nullify
or invalidate the third-party intellectual property right concerned or enter into a license agreement with the intellectual property
right holder, if available on commercially reasonable terms. There may also be pending patent applications that if they result in issued
patents, could be alleged to be infringed by our new products. If such an infringement claim should be brought and be successful, we
may be required to pay substantial damages, be forced to abandon our new products or seek a license from any patent holders. No assurances
can be given that a license will be available on commercially reasonable terms, if at all.

It
is also possible that we have failed to identify relevant third-party patents or applications.
For example, U. S. patent applications filed before November 29, 2000, and certain U. S. patent
applications filed after that date that will not be filed outside the United States remain
confidential until patents issue. Patent applications in the United States and in most of
the other countries are